GAMMA Investing LLC Grows Stock Position in Humana Inc. (NYSE:HUM)

GAMMA Investing LLC lifted its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 54.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,952 shares of the insurance provider's stock after purchasing an additional 1,046 shares during the quarter. GAMMA Investing LLC's holdings in Humana were worth $781,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Retirement Planning Co of New England Inc. raised its stake in shares of Humana by 4.7% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock worth $245,000 after purchasing an additional 43 shares during the last quarter. LFA Lugano Financial Advisors SA raised its stake in shares of Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares during the last quarter. Vise Technologies Inc. raised its stake in shares of Humana by 8.0% during the fourth quarter. Vise Technologies Inc. now owns 873 shares of the insurance provider's stock worth $221,000 after purchasing an additional 65 shares during the last quarter. Versant Capital Management Inc raised its stake in shares of Humana by 17.1% during the first quarter. Versant Capital Management Inc now owns 453 shares of the insurance provider's stock worth $120,000 after purchasing an additional 66 shares during the last quarter. Finally, Farther Finance Advisors LLC raised its stake in shares of Humana by 4.0% during the fourth quarter. Farther Finance Advisors LLC now owns 2,103 shares of the insurance provider's stock worth $533,000 after purchasing an additional 81 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Stock Up 0.8%

HUM opened at $241.82 on Monday. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.71. The firm has a market cap of $29.18 billion, a P/E ratio of 17.10, a PEG ratio of 1.82 and a beta of 0.43. Humana Inc. has a 52 week low of $212.45 and a 52 week high of $406.46. The business's fifty day simple moving average is $241.94 and its 200 day simple moving average is $259.20.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. The business had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 14.47% and a net margin of 1.42%. The business's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter last year, the company earned $7.23 earnings per share. As a group, equities research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.46%. The ex-dividend date of this dividend is Friday, June 27th. Humana's payout ratio is currently 25.04%.

Analyst Ratings Changes

HUM has been the subject of several analyst reports. Guggenheim assumed coverage on Humana in a research note on Wednesday, April 9th. They set a "buy" rating and a $326.00 price target for the company. Raymond James Financial raised Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective on the stock in a report on Thursday, May 1st. Truist Financial set a $280.00 price objective on Humana and gave the stock a "hold" rating in a report on Tuesday, June 17th. Bank of America dropped their price objective on Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a report on Tuesday, June 17th. Finally, Wall Street Zen raised Humana from a "hold" rating to a "buy" rating in a report on Friday. Sixteen investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $280.76.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.